Is there an association between anxiety and depression prior to and during pregnancy and gestational diabetes? An analysis of the Born in Bradford cohort by Wilson, Claire et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is there an association between anxiety and depression prior to
and during pregnancy and gestational diabetes? An analysis of
the Born in Bradford cohort
Citation for published version:
Wilson, C, Santorelli, G, Ismail, K, Reynolds, RM, Simonoff, E & Howard, L 2020, 'Is there an association
between anxiety and depression prior to and during pregnancy and gestational diabetes? An analysis of the
Born in Bradford cohort', Journal of affective disorders. https://doi.org/10.1016/j.jad.2020.07.019
Digital Object Identifier (DOI):
10.1016/j.jad.2020.07.019
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of affective disorders
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 31. Jul. 2020
Contents lists available at ScienceDirect
Journal of Affective Disorders
journal homepage: www.elsevier.com/locate/jad
Research paper
Is there an association between anxiety and depression prior to and during
pregnancy and gestational diabetes? An analysis of the Born in Bradford
cohort
Claire A Wilsona,⁎, Gillian Santorellib, Josie Dickersonb, Khalida Ismailc, Rebecca M Reynoldsd,
Emily Simonoffe, Louise M Howarda
a Section of Women's Mental Health, King's College London and South London and Maudsley NHS Foundation Trust, PO31 King's College London, De Crespigny Park,
London, SE5 8AF, UK
b Born in Bradford, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
c Department of Psychological Medicine, King's College London and South London and Maudsley NHS Foundation Trust, UK
d Centre for Cardiovascular Science, University of Edinburgh, UK
e Department of Child and Adolescent Psychiatry, King's College London and South London and Maudsley NHS Foundation Trust, UK
A R T I C L E I N F O
Keywords:
Diabetes
Gestational
Perinatal care
Common mental disorders
Born in Bradford
A B S T R A C T
Background: anxiety and depression are common in women with gestational diabetes but it is not clear whether
they are more likely to precede the onset of gestational diabetes or to co-occur with it. Our aims were to compare
the strength of association between common mental disorders of anxiety and depression (i) before pregnancy
and (ii) during pregnancy in women with and without gestational diabetes.
Methods: the sample comprised 12,239 women with 13,539 pregnancies from the UK's Born in Bradford cohort.
Gestational diabetes was diagnosed by oral glucose tolerance test (OGTT). Indicators of common mental dis-
orders were obtained from linked primary care records. Multivariable robust Poisson and logistic regression were
employed. Multiple imputation by chained equations was implemented to handle missing data. Models were
adjusted for maternal age, ethnicity, education and obstetric complications. Analyses of common mental dis-
orders during pregnancy were additionally adjusted for maternal smoking, pre-pregnancy BMI, multiple preg-
nancy and common mental disorders prior to pregnancy.
Results: there was no evidence for an association between common mental disorders prior to pregnancy and
gestational diabetes (adjusted RR 0.96; 95% CI 0.80,1.15) or between gestational diabetes and common mental
disorders during pregnancy (adjusted OR 0.91; 95% CI 0.73,1.12).
Limitations: high levels of deprivation and multi-ethnic composition of the cohort may limit generalisability of
these findings to other populations.
Conclusions: routine primary care records did not identify an increased risk of gestational diabetes in women
with common mental disorders prior to pregnancy or of gestational diabetes in women with common mental
disorders during pregnancy.
1. Introduction
Gestational diabetes mellitus (GDM) is diabetes which occurs for the
first time during pregnancy and has a global prevalence of between five
and 10 percent. It is associated with negative outcomes for mother and
baby, including obstetric complications (Kampmann et al., 2015) and
adverse metabolic and neuro-behavioural outcomes in offspring
(Ornoy, 2005).
The common mental disorders (CMD) of anxiety and depression are
also common morbidities to affect women both during and prior to
pregnancy; they too are associated with adverse obstetric and longer-
term offspring outcomes (Howard et al., 2014). There is an increasing
awareness of the physical-mental health interface and there is now a
body of research supporting a bidirectional relationship between de-
pression and Type 2 diabetes (Moulton et al., 2015). However, the
physical-mental health interface in pregnancy, in particular the asso-
ciation between GDM and CMD has been relatively less investigated.
Given that there is the pathophysiology of insulin resistance common to
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both GDM and Type 2 diabetes, we hypothesised that there may be an
association between GDM and CMD. Potential mechanisms for this as-
sociation between GDM and CMD include insulin resistance secondary
to placental hormone secretion, inflammation and shared socio-
environmental risk factors (Osborne and Monk, 2013).
In a recent systematic review and meta-analysis, we found an in-
creased risk of depression in women with GDM, with the greatest risk
during pregnancy, around the time of GDM diagnosis (Wilson et al.,
2020). None of the studies were of a UK population and despite an
increasing awareness of the influence of preconception mental health
on pregnancy outcomes (Patton et al., 2018; Wilson et al., 2018) there
have been few studies investigating the risk of GDM in women with
preconception mental disorders. A small number of North American
cohorts have found an increased risk of GDM in women with anxiety
and depression prior to pregnancy (Beka et al., 2018; Bowers et al.,
2013; Clark et al., 2019) but it is not clear the extent to which these
findings generalise to a UK population.
Thus the aim of this study was to investigate the relationship be-
tween GDM and CMD both prior to and during pregnancy in the UK's
Born in Bradford cohort. We hypothesised that there would be an as-
sociation with GDM in women with CMD prior to pregnancy and also
during pregnancy.
2. Methods
2.1. Sample
Born in Bradford (BiB) is a prospective longitudinal cohort of
12,450 women with 13,758 pregnancies in Bradford. Bradford is a city
in the north of England and one of the most economically deprived
urban areas of the UK, with 60% of babies born in Bradford being born
into the poorest 20% of the English and Welsh population according to
Index of Multiple Deprivation. Its ethnic makeup is predominantly bi-
ethnic: Pakistani and White British.
Pregnant women were recruited to BiB between 2007 and 2010
(Wright et al., 2013), when attending a routine appointment for a two
hour 75g oral glucose tolerance test: OGTT; this is currently re-
commended by the UK's National Institute for Health and Care Ex-
cellence (NICE) as gold standard for diagnosing GDM (National In-
stitute for Health and Care Excellence (NICE), 2015). It is offered to all
women in Bradford and this is usually between 26 and 28 weeks ge-
station. Consent was obtained for record linkage to maternity and pri-
mary care records via SystmOne: a clinical computer system used by
almost all general practices in Bradford and which provides primary
care data on diagnoses and prescriptions. Women without linkage to
primary care records or with pre-gestational diabetes (Types 1 and 2)
were excluded from the analyses (see Fig 1). This gave a final sample of
12,239 women with 13,539 pregnancies.
2.2. Measures
2.2.1. GDM
GDM was diagnosed according to modified World Health
Organisation (WHO) criteria (either fasting glucose ≥6·1 mmol/l or
two hour post-load glucose ≥7·8 mmol/l) (Farrar et al., 2015). The
primary outcome was a binary variable of GDM or no GDM. Fasting
glucose results were also analysed as a continuous variable in sensi-
tivity analyses.
2.2.2. Common mental disorders (CMD)
As an indicator of CMD, Read codes (CTV version 3) for diagnosis
and/or treatment of CMD were used alongside medication prescriptions
as per previously published methods (Prady et al., 2016). These relate
to ICD-10 diagnostic groups F32 and F33 depressive episodes and re-
current depressive disorders and F41 anxiety disorders (WHO, 1990).
‘Preconception’ CMD as a binary variable was defined as any indicator
of CMD that was dated from the woman's birth to the date of conception
(estimated from date of last menstrual period and/or booking scan) of
the woman's first ever pregnancy. The binary variable of ‘antenatal’
CMD was defined as any indicator appearing between the date of
conception and the date of delivery for each pregnancy in the BiB co-
hort. Further information on the codes used is provided in supple-
mentary material (S1).
2.2.3. Confounders
There were a number of variables identified as potential con-
founders due to their association with both GDM and CMD but not on
the causal pathway from exposure to outcome (VanderWeele, 2019).
These included maternal age (Anna et al., 2008; McManus et al., 2016)
at the time of the OGTT and other obstetric complications that usually
occur around the same time as GDM (as a binary variable of pre-
eclampsia and/or gestational hypertension) (Alder et al., 2007;
Kim et al., 2005; Xiong et al., 2001). Also included were the socio-
demographic characteristics of maternal ethnicity (as a three category
variable of Pakistani, White British or Other) and socioeconomic status
(SES) (Anna et al., 2008; Bhui et al., 2001; Howard et al., 2014); rather
than using index of multiple deprivation (Department for Communities
and Local Government, 2015) to assign SES, a five category variable of
maternal education was used a proxy, as the high levels of deprivation
in BiB result in a highly skewed distribution of participants across de-
privation categories. Analyses of antenatal CMD additionally controlled
for preconception CMD, any tobacco smoking during pregnancy (Bar-
Zeev et al., 2020; Tong et al., 2016), singleton versus multiple preg-
nancy (Ben‐Haroush et al., 2004; Ross et al., 2011) and the continuous
variable of BMI (body mass index) at pregnancy booking as a measure
of pre-pregnancy BMI (Molyneaux et al., 2014).
2.3. Statistical analysis
Data were analysed using Stata version 15 (StataCorp, 2007).
Multivariable robust Poisson and logistic regression were employed to
examine the associations between GDM with preconception CMD and
antenatal CMD respectively, within a generalised estimating equation
framework using the robust sandwich estimator for standard errors to
account for multiple pregnancy clustering. Two analyses were per-
formed: unadjusted and adjusted for the confounders described above,
to produce risk ratios (RR) for the Poisson regression models and odds
ratios (OR) for the logistic regression models. An interaction term for
ethnicity was also included in the models.
Multiple imputation by chained equations was implemented to
handle missing data (White et al., 2011). 35 imputations were used
according to the proportion of participants with any missing data
(Bodner, 2008). All analysis variables were included in the imputation
model. Estimates were obtained by pooling results using Rubin's rules
(Rubin, 1987). Complete case analyses were also conducted (see sup-
plementary material).
2.3.1. Subgroup analyses
Analyses were stratified into two groups of Pakistani and White
British ethnicity, using the above analysis but with the removal of
ethnicity as a covariate. As these were the most prevalent ethnicities,
further categories of ethnicity such as ‘Other’ would have been too
heterogeneous.
2.3.2. Sensitivity analyses
The following sensitivity analyses were performed on the full
sample in addition to the primary analysis:
(1) The continuous variable of fasting glucose was used instead of the
binary GDM variable used in the primary analyses using linear re-
gression.
(2) The primary GDM variable was also re-classified using fasting and
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two hour post-load glucose from OGTT. Given the widespread de-
bate surrounding GDM diagnosis (Koning et al., 2018), two dif-
ferent sets of diagnostic criteria were applied: 1) current NICE cri-
teria (either fasting ≥5.6 mmol/l or two hour post-load glucose
≥7·8 mmol/l) (National Institute for Health and Care Excellence
(NICE) 2015) and 2) current WHO and International Association of
Diabetes and Pregnancy Study Groups (IADPSG) criteria (either
fasting ≥5.1 mmol/l or two hour post-load glucose ≥8.5 mmol/l)
(Metzger, Gabbe et al. 2010).
(3) In the analyses involving antenatal CMD, the binary GDM variable
was replaced with a three-category variable of 1) no GDM, 2) GDM
not treated with insulin and 3) GDM treated with insulin.
(4) Prescription codes were removed from both the preconception and
antenatal CMD variables and CMD classification based solely on
Read codes to investigate any potential misclassification bias
(Thielen et al., 2009).
3. Results
The demographics of BiB are broadly representative of Bradford as a
whole (Wright et al., 2013). Characteristics of the sample and the
proportion of missing data in each variable are presented in Table 1.
This data stratified by GDM status is also available in supplementary
material (S2). 45% of the pregnancies with data on ethnicity were from
women of Pakistani ethnicity and mean maternal age was 27 years
(standard deviation (SD) 5.6). 26% of the pregnancies with data on
education were from women with education higher than A level. Mean
booking BMI was 26 kg/m2 (SD 5.7). 155 of the pregnancies were non-
singleton, 763 pregnancies were affected by pre-eclampsia and/or ge-
stational hypertension and 1028 by GDM (8% of pregnancies with
known GDM status). 16% of the pregnancies with data on smoking
status were from women who reported tobacco use at some point
during pregnancy. 17% of the pregnancies with available data were
from women with an indicator of preconception CMD and 11% with an
indicator of antenatal CMD.
3.1. The association between preconception CMD and GDM
3.1.1. Primary analyses
Table 2 displays the results of the association between the exposure
Fig. 1. How the sample was obtained.
Table 1
Characteristics of the sample (N=13,539 pregnancies).
n %
Ethnicity
Pakistani 5071 37.5
White British 4425 32.7
Other 1725 12.7
Missing 2318 17.1
Maternal age (years)
Mean (SD) 27.31 (5.6)
Missing 1345 9.9
Multiple pregnancy
Singleton 13004 96.1
Multiple pregnancy (twins or triplets) 155 1.1
Missing 380 2.8
Maternal education
Less than 5 GCSE equivalents 2413 17.8
5 GCSE equivalents 3451 25.5
A level equivalents 1622 12.0
Higher than A level 2870 21.2
Other 859 6.3
Missing 2324 17.2
Pre-pregnancy BMI
Mean (SD) 26.03 (5.7)
Missing 3167 23.4
Obstetric complication (pre-eclampsia and/or gestational hypertension)
Yes 763 5.6
No 11820 87.3
Missing 956 7.1
Maternal tobacco smoking in pregnancy
Yes 1847 13.6
No 9377 69.3
Missing 2315 17.1
Preconception CMD
Yes 2119 15.7
No 10099 74.6
Missing 1321 9.8
Antenatal CMD
Yes 1423 10.5
No 11916 88.0
Missing 200 1.5
GDM
Yes 1028 7.6
No 12044 89.0
Missing 467 3.5
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of preconception CMD and the outcome of GDM using imputed data.
There was some evidence of an effect of preconception CMD on reduced
risk for GDM in the unadjusted model. However, this risk was atte-
nuated in the adjusted model. Results of complete case analyses mir-
rored those of the imputed results; see supplementary material (S3).
There was no evidence of an interaction between preconception CMD
and ethnicity on risk for GDM (p=0.12 for the interaction term of
preconception CMD and ethnicity).
3.1.2. Subgroup analyses
There was also little evidence of an association between pre-
conception CMD and GDM within ethnic groups (adjusted RR for
women of Pakistani ethnicity 0.92; 95% CI 0.70,1.21 and adjusted RR
for women of White British ethnicity 1.05; 95% CI 0.78,1.41), although
the direction of effect differed slightly between ethnic groups.
Prevalence of GDM was higher in women of Pakistani than White
British ethnic origin but White British were more likely to have an in-
dicator of preconception CMD; see supplementary material (S4).
3.1.3. Sensitivity analyses
The sensitivity analyses provided little evidence of an association
between preconception CMD and fasting glucose as a continuous vari-
able (adjusted beta 1.01; 95% CI 0.98,1.04). When GDM was classified
according to NICE criteria, the proportion of pregnancies affected by
GDM in the imputed data was 9.7% (versus 7.9% in the primary ana-
lyses). Despite the increased proportion with GDM, this translated into
a largely unchanged effect estimate for the association with pre-
conception CMD (adjusted RR 0.96; 95% CI 0.81,1.13). 13.4% of
pregnancies were affected by GDM according to WHO and IADPSG
diagnostic criteria, with adjusted RR following exposure to pre-
conception CMD also being similar to that of the primary analyses at
1.08; 95% CI 0.94,1.23. When preconception CMD was classified using
only Read codes, with prescriptions excluded, this resulted in little
change to the effect estimate from primary analysis (adjusted RR 0.86;
95% CI 0.69,1.08).
3.2. The association between GDM and antenatal CMD
3.2.1. Primary analyses
The imputed results of the association between the exposure of GDM
and the outcome of antenatal CMD are shown in Table 3. There was no
evidence of an association on unadjusted or adjusted analyses. Results
of complete case analyses mirrored those of the imputed results; see
supplementary material (S3). There was no evidence of an interaction
between GDM and ethnicity on risk for antenatal CMD (p=0.41 for the
interaction term of GDM and ethnicity).
3.2.2. Subgroup analyses
There was also little evidence of an association within ethnic groups
(adjusted OR for women of Pakistani ethnicity 1.16; 95% CI 0.87,1.55
and adjusted OR for women of White British ethnicity 0.75; 95% CI
0.46,1.22), although the direction of effect differed slightly between
ethnic groups. Women of White British ethnic origin were more likely
to have an indicator of antenatal CMD (supplementary material S4).
3.2.3. Sensitivity analyses
The sensitivity analyses using fasting glucose as a continuous vari-
able in place of the binary GDM variable produced no evidence of an
association with antenatal CMD (adjusted OR 0.99; 95% CI 0.88,1.12),
nor was there evidence of an association when GDM was re-classified
according to NICE (adjusted OR 0.88; 95% CI 0.71,1.09) or WHO and
IADPSG criteria (adjusted OR 1.02; 95% CI 0.85,1.23). Likewise, there
was no evidence of a difference between groups when GDM was used as
a three-category variable encompassing use of insulin; adjusted OR for
antenatal CMD in GDM treated with insulin was 0.93 (95% CI
0.70,1.23) and without insulin was 0.88 (0.64,1.21). When antenatal
CMD was classified using only Read codes, this also resulted in little
change to the effect estimate from primary analysis (adjusted OR 0.90;
95% CI 0.61,1.31).
4. Discussion
4.1. Main findings
There was no evidence of an association between primary care in-
dicators of CMD prior to pregnancy (preconception CMD) and GDM and
between GDM and CMD during pregnancy (antenatal CMD) in a large,
multi-ethnic UK birth cohort. There was little evidence for a difference
between ethnicities in the association between GDM and CMD in both
the preconception and antenatal periods. Reconceptualising the diag-
nosis of GDM by using fasting glucose or different diagnostic criteria
made little difference to these results.
4.2. Comparison with previous findings
Research to date on the relationship between GDM and CMD during
pregnancy has yielded mixed results; some studies have found evidence
of an association, while others have not (Byrn and Penckofer, 2013;
Ross et al., 2016). The smaller number of studies examining the asso-
ciation between CMD prior to pregnancy and subsequent GDM have
provided evidence supporting a relationship (Beka et al., 2018;
Bowers et al., 2013; Clark et al., 2019). Our own meta-analysis of stu-
dies during pregnancy and up to one year postpartum, while finding an
increased risk of depression in women with GDM during pregnancy,
found substantial heterogeneity between studies measuring both
symptoms and diagnoses of depression and anxiety (Wilson et al.,
Table 2
Associations between preconception CMD and GDM (N=13,539 pregnancies).
GDM
Unadjusted % RR (95% CI) p-value
Preconception CMD Reference category= no
indicator
8.2 1.00
Preconception CMD indicator 6.4 0.78 (0.65,
0.94)
0.007
Adjusted* % RR (95% CI) p-value
Preconception CMD Reference category= no
indicator
8.2 1.00
Preconception CMD indicator 6.4 0.96 (0.80,
1.15)
0.658
Models using Poisson regression within a generalised estimating equation fra-
mework with robust standard errors
⁎ adjusted for maternal age, education, ethnicity and obstetric complications
of pre-eclampsia and/or gestational hypertension.
Table 3
Associations between GDM and antenatal CMD (N=13,539 pregnancies).
Antenatal CMD
Unadjusted % OR (95% CI) p-value
GDM Reference category= no GDM 10.7 1.00
GDM 10.2 0.95 (0.77, 1.17) 0.632
Adjusted* % OR (95% CI) p-value
GDM Reference category= no GDM 10.7 1.00
GDM 10.2 0.91 (0.73, 1.12) 0.368
Models using logistic regression within a generalised estimating equation fra-
mework with robust standard errors
⁎ adjusted for maternal age, education, ethnicity, multiple pregnancy, ob-
stetric complications, preconception CMD, maternal smoking and pre-preg-
nancy BMI.
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2020). Sources of this heterogeneity include variation in measurement
of both GDM and mental disorder and also variation in study designs
and populations. Indeed most of the studies, which were observational
in their design, we assessed as at high risk of bias in their sampling and/
or measurement (Wilson et al., 2020). While in our meta-analysis we
conducted a number of sensitivity analyses to try to identify similarities
in results within studies of a similar design, for example measurement
using diagnostic versus screening tools of mental disorder, no clear
trends emerged (Wilson et al., 2020). We discuss below some of the
strengths of this particular study in the Born in Bradford (BiB) cohort
which may have resulted in more conservative effect estimates than
that seen in other studies. Other unique aspects of the Bradford popu-
lation are its high proportion of women of South Asian ethnicity, in
which diabetes (both gestational and Type 2) is more common
(Di Cianni et al., 2018; Kampmann et al., 2015) so perhaps the ex-
perience of GDM is less troubling in these communities than in other
ethnic groups in which diabetes is less prevalent.
Another limitation of previous studies is that they often do not re-
port how GDM was diagnosed or consider how the degree of hy-
perglycaemia may have impacted results. In this study the glucose re-
sults of the OGTT were used to consider whether or not the level of
hyperglycaemia may have affected risk. This is an important con-
sideration since there is now some evidence of a relationship between
elevated maternal glucose concentrations below that of overt diabetes
and adverse outcomes (The HAPO Study Cooperative Research
Group, 2008). This has caused some to argue that GDM should be
conceptualised as a continuum of glucose intolerance and has also led
to widespread debate around the diagnostic criteria for GDM
(Koning et al., 2018). While one study has reported a positive corre-
lation between levels of hyperglycaemia and depressive and anxiety
symptoms (Gezginç et al., 2013), another study found no difference in
glucose tolerance between depressed versus healthy groups (Sit et al.,
2014). Indeed in the sensitivity analyses we found no evidence for as-
sociations with fasting glucose from the OGTT or GDM treated with
insulin versus without. We also found no difference in these results
when was GDM re-classified according to various diagnostic criteria.
This is an important consideration given the recent debate surrounding
diagnostic criteria for GDM (Cundy and Holt, 2017).
4.3. Strengths and limitations
The BiB cohort provided data that facilitated in-depth exploration of
the relationship between GDM and CMD: the first in a UK population.
The comprehensive glucose profiles provided by systematic testing for
GDM with the OGTT in the cohort also allowed for consideration of how
the degree of hyperglycaemia may be influenced by CMD. The multi-
ethnic composition of the cohort also facilitated analysis of possible
ethnic differences in risk, which has been relatively neglected in the
GDM and CMD literature to date (Wilson et al., 2020). There were no
significant differences in the association between GDM and CMD ob-
served in this study on stratification by ethnicity.
However, one of the study's limitations is that there may be un-
derdiagnosis of anxiety and depression in primary care (Cepoiu et al.,
2008; John et al., 2016). While the prevalence of CMD from primary
care indicators in this study is comparable to that of the general po-
pulation in both the preconception (Copeland et al., 2011; Moffitt et al.,
2010) and antenatal periods (Howard et al., 2014), previous analyses of
the BiB cohort using screening tools for mental disorder administered in
the cohort have suggested that CMD in women of Pakistani ethnicity is
twice as likely to be undiagnosed in primary care as women of White
British ethnicity (Prady et al., 2016). Indeed in our analyses we also
found that women of Pakistani ethnicity were less likely than White
British to have an indicator of CMD recorded by primary care in both
the preconception and antenatal periods. Research suggests that this
under-diagnosis may be for a number of reasons, including stigma and
somatisation of symptoms (Bhui et al., 2001; Bhui et al., 2004).
Conclusions
This is the first study in the UK to examine the relationship between
GDM and CMD, although the findings in this multi-ethnic cohort with
high levels of deprivation may not generalise to other populations. The
lack of evidence for an association in this population between CMD
before and during pregnancy and GDM should provide some reassur-
ance to women with GDM and/or CMD.
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